← Leaderboards
Gerard A Silvestri
University Of Florida
$1,890,265
Attributed
$4,103,913
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $689.4K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,103,913 · 2
By mechanism
R01$3,320,472 · 1
K24$783,441 · 1
Top collaborators
- Dejana K Braithwaite7 shared
- Michael K Gould7 shared
Most similar at University Of Florida
Same institution · by research overlap
- Yi Guo$3,756,653
- Dejana K Braithwaite$4,149,456
- Michael K Gould$4,461,814
- Christopher E Forsmark$2,643,269
- Elizabeth A Shenkman$13,048,879
Others in their field
Top investigators on “Malignant Neoplasm Of Lung”
- David Heimbrook · Leidos Biomedical Research, Inc.$349,639,893
- Richard K. Wilson · Washington University$202,666,376
- Walter John Curran · Thomas Jefferson University$94,674,902
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$61,410,512
- Norman Wolmark · Nsabp Foundation, Inc.$54,610,124
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
Research focus
Malignant Neoplasm Of LungCancer EtiologyCessation Of LifeClinical PracticeBaseCancer PatientEligibility DeterminationEthnic OriginEarly ScreeningEarly DiagnosisCompare EffectivenessDecision MakingElderlyCancer SurgeryDiagnosisComorbidityAdultData StandardsChronicAttentionCancer InterventionDiagnostic ProcedureAmerican Cancer SocietyElectronic Health Record
Grant awards (13)
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$637,797
R01 · FY2025 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$608,786
R01 · FY2024 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$65,002
R01 · FY2024 · CA
Diversity Supplement: Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$55,355
R01 · FY2023 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$626,652
R01 · FY2022 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$637,512
R01 · FY2021 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$689,368
R01 · FY2020 · CA
K24 Mid-Career Investigator Award in Patient-Oriented Research$146,799
K24 · FY2011 · CA · contact PI
K24 Mid-Career Investigator Award in Patient-Oriented Research$145,649
K24 · FY2010 · CA · contact PI
K24 Mid-Career Investigator Award in Patient-Oriented Research$144,531
K24 · FY2009 · CA · contact PI
K24 Mid-Career Investigator Award in Patient-Oriented Research$107,775
K24 · FY2009 · CA · contact PI
K24 Mid-Career Investigator Award in Patient-Oriented Research$131,394
K24 · FY2008 · CA · contact PI
K24 Mid-Career Investigator Award in Patient-Oriented Research$107,293
K24 · FY2007 · CA · contact PI